Method for coating pharmaceutical substrates
The present invention relates to the field of coating pharmaceutical substrates. In particular, the invention relates to methods of coating of pharmaceutical substances, pharmaceutical ingredients or a blend of them. The invention also provides a method of making a pharmaceutical formulation which may be processed into a pharmaceutical dosage form, which utilizes solid pharmaceutical particles and a pharmaceutical formulation obtained by the method. The methods of the invention utilize atomic layer deposition technology. The novel methods allow difficult, moisture sensitive and electrically charged pharmaceutical substrates to be easily processable.
1. A method for improving flowability and processability of nanoparticles or microparticles consisting of an active pharmaceutical substance, the method comprising:
providing nanoparticles or microparticles consisting of an active pharmaceutical substance and depositing a pinhole free coating layer over the nanoparticles or microparticles by subjecting surfaces of the nanoparticles or microparticles to alternating surface reactions of at least a first and a second gaseous precursor by an atomic layer deposition method to provide coated nanoparticles or microparticles,
wherein said method further comprises combining the coated nanoparticles or microparticles of an active pharmaceutical substance with one or more excipients and compressing into a dosage form.
2. The method of claim 1 , wherein said coating layer comprises an inorganic or organic material or a combination thereof.
3. The method of claim 2 , wherein the inorganic material comprises a metal oxide.
4. The method of claim 3 , wherein said metal oxide is aluminum oxide or titanium oxide.
5. The method of claim 2 , wherein said inorganic or organic material comprises a taste-making agent.
6. The method of claim 1 , wherein the excipient is not a binder or filler.
7. The method of claim 1 , wherein the active pharmaceutical substance is paracetamol.
8. The method of claim 1 , wherein said dosage form is a tablet.
9. The method of claim 1 , wherein said alternating surface reactions comprise alternately depositing coatings of AlO 3 and TiO 2 .
10. The method of claim 9 , wherein said coating of TiO 2 is deposited by depositing a layer of trimethylaluminum followed by reaction with water.
11. The method of claim 9 , wherein said coating of TiO 2 is deposited by depositing a layer of tetrakis(dimethylamido)titanium followed by reaction with water.
12. The method of claim 9 , wherein said coating of AhO 3 is deposited by depositing a layer of trimethylaluminum followed by reaction with water, and wherein said coating of TiO 2 is deposited by depositing a layer of tetrakis(dimethylamido)titanium followed by reaction with water.
13. The method of claim 1 , wherein said microparticles consisting of an active pharmaceutical substance have a size of approximately 50 microns.
14. The method of claim 1 , wherein the pharmaceutical substance to be coated is a biomolecule selected from one or more of a peptide, polypeptide, oligonucleotide, nucleic acid, and gene.
15. The method of claim 1 , wherein the pharmaceutical substance to be coated is a small molecule selected from one or more of a nucleotide, amino acid, sugar, carbohydrate, lipid, and compound which has a molecular weight of less than 100 kD.
16. The method of claim 1 , wherein the pharmaceutical substance to be coated is a cell.